By G HossainPosted on September 10, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The autoimmune and inflammatory disease–focused company canceled plans to go public earlier this year as the IPO window slammed shut. Odyssey Rebounds Off Failed IPO With $213M Series D Post navigation Novo’s Headcount Rose 81% in Five Years as Revenue ClimbedAccounting Today calls for nominations for Top 100 People